Centaurea borysthenica
Centaurea borysthenica · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Centaurea borysthenica is a medicinal plant species that has garnered increasing scientific interest due to its complex phytochemical profile. Recent pharmacological investigations have focused on the potential therapeutic effects of its methanolic extracts. Specifically, studies have explored how these concentrated extracts interact with biological systems under varying chemical conditions. A primary area of focus involves evaluating their impact and protective mechanisms against the cytotoxic effects of Doxorubicin. Understanding these interactions provides critical insights into the plant's potential role in mitigating chemotherapy-induced damage.
- Synonyms
- Centaurea Arenaria Subsp. Borysthenica · Acosta Borysthenica
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Centaurea borysthenica is a distinct plant species known by several different regional names. In Russian-speaking contexts, it is commonly referred to as Василек днепровский. When spoken in Ukrainian, the plant is identified as Волошка дніпровська. These linguistic variations reflect the diverse cultural connections to the species across different regions. Understanding these common names helps researchers and enthusiasts identify the plant regardless of the local language.
Sources: Catalogue of Life (COL)
Synonyms
Centaurea borysthenica is a botanical species that is recognized by several different scientific names within the taxonomic record. One notable synonym used to identify this plant is Acosta borysthenica. Additionally, it is frequently classified under the name Centaurea arenaria subsp. borysthenica in various studies. These overlapping designations reflect the complex history of its classification and evolving botanical nomenclature. Understanding these relationships is essential for researchers seeking to accurately identify the plant across different scientific literatures.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Centaurea borysthenica is a distinctive member of the kingdom Plantae. Within this vast biological realm, the species belongs to the class Equisetopsida. It is further categorized under the order Asterales, which highlights its evolutionary connections. As a part of the diverse family Asteraceae, it shares traits with many common flowering plants. Ultimately, this species is classified under the specific genus Centaurea.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Centaurea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Centaurea borysthenica is a notable species with a broad distribution spanning several distinct regions across the European continent. Its range extends through Eastern Europe and into East European Russia, including significant presence within Ukraine. Moving toward the center of the continent, the plant is also established throughout Middle Europe, specifically within Hungary. The species reaches further south into Southeastern Europe, where it can be found throughout the Northwest Balkan Peninsula. Finally, its regional footprint is well-documented within the borders of Romania, completing its diverse geographic profile.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Centaurea borysthenica is characterized by its distinct herbaceous growth form. This plant displays a versatile stature, with heights ranging from a minimum of 0.25 m. Under optimal conditions, it can reach a maximum height of 1.2 m.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Centaurea borysthenica provides a protective effect on cardiomyocytes that have been treated with the chemotherapy drug doxorubicin. This plant's methanolic extract demonstrates significant activity in maintaining cell viability and mitigating oxidative stress caused by the drug. Research indicates that the extract acts as a cardioprotective agent by stabilizing mitochondrial membrane potential in rat heart cells. While it is highly effective at preventing doxorubicin-induced cardiotoxicity, using the extract in higher concentrations can weaken the overall efficacy of the drug. Ultimately, the antioxidant properties of Centaurea borysthenica offer a potential strategy for managing the side effects of cancer therapy.
Preparations
Centaurea borysthenica is prepared as methanolic extracts to investigate its phytochemical composition and protective properties. These specific extracts are derived from the aerial parts of the plant for scientific evaluation. Researchers utilize these methanolic preparations to study their potential to combat oxidative stress in cardiomyocytes. The study specifically focuses on how the methanolic extract of this species can mitigate the cardiotoxicity caused by doxorubicin. Ultimately, the preparation of Centaurea borysthenica into methanolic extracts serves as a method to harness its antioxidant activity for medical prevention.